LEADER 02611nam 22008413u 450 001 9910789578403321 005 20220914000617.0 010 $a2-7420-1234-6 035 $a(CKB)3710000000025020 035 $a(EBL)3317898 035 $a(SSID)ssj0001048635 035 $a(PQKBManifestationID)12381905 035 $a(PQKBTitleCode)TC0001048635 035 $a(PQKBWorkID)11017933 035 $a(PQKB)11028185 035 $a(MiAaPQ)EBC3317898 035 $a(PPN)185797083 035 $a(EXLCZ)993710000000025020 100 $a20151005d2014|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aOrphan Drugs in Epilepsy$b[electronic resource] 210 $aMontrouge $cJOHN LIBBEY EUROTEXT$d2014 215 $a1 online resource (90 p.) 225 1 $aTopics in Epilepsy ;$vv.4 300 $aDescription based upon print version of record. 311 $a2-7420-0810-1 327 $a""Orphan Drugs in Epilepsy""; ""Contents""; ""Foreword""; ""Bromides""; ""Adrenocorticotropic hormone and corticosteroids""; ""Stiripentol""; ""Felbamate""; ""Rufinamide"" 410 0$aTopics in Epilepsy 606 $aEpilepsy -- Treatment 606 $aBrain Diseases 606 $aCentral Nervous System Agents 606 $aDrug Industry 606 $aIndustry 606 $aTherapeutic Uses 606 $aCentral Nervous System Diseases 606 $aNervous System Diseases 606 $aTechnology, Industry, and Agriculture 606 $aPharmacologic Actions 606 $aChemical Actions and Uses 606 $aDiseases 606 $aAnticonvulsants 606 $aEpilepsy 606 $aOrphan Drug Production 615 4$aEpilepsy -- Treatment. 615 2$aBrain Diseases 615 2$aCentral Nervous System Agents 615 2$aDrug Industry 615 2$aIndustry 615 2$aTherapeutic Uses 615 2$aCentral Nervous System Diseases 615 2$aNervous System Diseases 615 2$aTechnology, Industry, and Agriculture 615 2$aPharmacologic Actions 615 2$aChemical Actions and Uses 615 2$aDiseases 615 2$aAnticonvulsants 615 2$aEpilepsy 615 2$aOrphan Drug Production 676 $a616.853 700 $aNikanorova$b Marina$01568653 701 $aJohannessen$b Svein I$01568654 701 $aGenton$b Pierre$01528106 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a9910789578403321 996 $aOrphan Drugs in Epilepsy$93840930 997 $aUNINA